(4Z,6Z,8R,9R,10Z,12R,13R,14R,16S)-19-{[2-(dimethylamino)ethyl]amino}-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate

• ChemBase编号: 2783
• 分子式: C32H48N4O8
• 平均质量: 616.74552
• 单一同位素质量: 616.34721452
• SMILES: CO[C@@H]1C[C@@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)/C(=C\C=C/[C@@H](OC)[C@H](OC(=O)N)/C(=C\[C@@H](C)[C@H]1O)/C)/C)C2=O
• Canonical SMILES: CO[C@@H]1C[C@@H](C)CC2=C(NCCN(C)C)C(=O)C=C(C2=O)NC(=O)/C(=C\C=C/[C@H]([C@@H](/C(=C\[C@H]([C@H]1O)C)/C)OC(=O)N)OC)/C
• InChI: InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10-,21-16-/t18-,20+,25+,26+,28+,30+/m0/s1
• InChIKey: KUFRQPKVAWMTJO-QSTRRNJOSA-N

名称和登记号

名称

• IUPAC标准名: (4Z,6Z,8R,9R,10Z,12R,13R,14R,16S)-19-{[2-(dimethylamino)ethyl]amino}-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
• IUPAC传统名: @17-dmag
• 别名: 17-Dmag

登记号

• PubChem SID: 46504670; 160966231
• PubChem CID: 46936572

理论计算性质

JChem

• Acid pKa: 12.775154
• 质子受体: 9
• 质子供体: 4
• LogD (pH = 5.5): 0.041767485
• LogD (pH = 7.4): 1.5928986
• Log P: 1.8524113
• 摩尔折射率: 172.3793 cm^3
• 极化性: 64.97228 Å^3
• 极化表面积: 169.52 Å^2
• 可自由旋转的化学键: 8
• 里宾斯基五规则: false

ALOGPS 2.1

• Log P: 1.84
• LOG S: -4.47
• 溶解度: 2.11e-02 g/l

详细说明

DrugBank - DB03080

Drug information: experimental